FindTrial
Sign In

Changes in intracellular metabolism of pancreatic neuroendocrine tumors

Changes in intracellular metabolism of pancreatic neuroendocrine tumors - Changes in intracellular metabolism of pancreatic neuroendocrine tumors

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049580
Enrollment
46
Registered
2022-11-21
Start date
2022-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic neuroendocrine tumors

Interventions

None listed

Sponsors

Hokkaido University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Agreement to participate to this study

Exclusion criteria

Exclusion criteria: Participants who thought to be inappropriate to enter this study for some reasons by physician's judgments

Design outcomes

Primary

MeasureTime frame
1) The extent of PFKFB3 expression in pancreatic neuroendocrine tumors 2) PFKFB3-positive beta cell ratio in the islets accompanied by pancreatic neuroendocrine tumors—

Secondary

MeasureTime frame
1) Comparison of PFKFB3-positive beta cell ratio in the islets between non-diabetics and patients with diabetes 2) Relationship between PFKFB3 positive ratio and cell proliferation in pancreatic neuroendocrine tumors 3) Relationship between PFKFB3 positive ratio in pancreatic neuroendocrine tumors and patients' background characteristics 4) Relationship between PFKFB3 positive beta cell ratio in islets and patients' background characteristics—

Countries

Japan

Contacts

Public ContactHiroshi Nomoto

Hokkaido University Hospital Department of diabetology and endocrinology

hnomoto@med.hokudai.ac.jp0117065915

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026